Similar articles

• Intralesional immunotherapy for the management of warts.

  Chandrashekar L. Chandrashekar L. Indian J Dermatol Venereol Leprol. 2011 May-Jun;77(3):261-3. doi: 10.4103/0378-6323.79694. Indian J Dermatol Venereol Leprol. 2011. PMID: 21508563 No abstract available.
• Immunotherapy or not? The mystery deepens.

  Rohatgi S, Kerure AS, Udare S, Jerajani HR. Rohatgi S, et al. Indian J Dermatol Venereol Leprol. 2016 Jul-Aug;82(4):417-8. doi: 10.4103/0378-6323.182970. Indian J Dermatol Venereol Leprol. 2016. PMID: 27279302 No abstract available.
• Intralesional immunotherapy with Mycobacterium w vaccine in patients with multiple cutaneous warts: uncontrolled open study.

  Meena JK, Malhotra AK, Mathur DK, Mathur DC. Meena JK, et al. JAMA Dermatol. 2013 Feb;149(2):237-9. doi: 10.1001/jamadermatol.2013.866. JAMA Dermatol. 2013. PMID: 23426493 Clinical Trial. No abstract available.
• [Treatment of warts].

  Combemale P, Delolme H, Dupin M. Combemale P, et al. Ann Dermatol Venereol. 1998 Jul;125(6-7):443-62. Ann Dermatol Venereol. 1998. PMID: 9747307 Review. French. No abstract available.
• Warts. Biology and current therapy.

  Pass F. Pass F. Minn Med. 1974 Oct;57(10):844-7, 852. Minn Med. 1974. PMID: 4138814 Review. No abstract available.